Matt Maurer to speak at the Measurement Matters Symposium

Matt Maurer will be speaking at the LGC Standards' Measurement Matters Symposium on "The evolution of regulation and testing in the cannabis & cannabinoids market" on February 24, 2021. 

Join online for a day of expert insight and conversation 

The multi-stream agenda will spotlight both emerging trends and topics of consistent interest to the research and analytical science community around the globe, with panel sessions of international experts, presentations and case studies focused on key issues, and innovative poster sessions. 

Wherever you are

The free-to-attend digital symposium will bring together audience and speakers from across the world to cover topical laboratory and regulatory issues relevant to many global markets.

The day’s agenda will include sessions on:

  • The evolution of regulation and testing in the cannabis & cannabinoids market
  • Worldwide food fraud and authenticity challenges
  • Synthetic cannabinoids for pharmaceutical research
  • Global traceability and accuracy in pharmaceutical testing
  • Proficiency testing for the detection of SARS-CoV-2
  • Another new normal: Nitrosamine testing for pharmaceutical products
  • Ensuring the quality of extra virgin olive oil
  • Identifying unusual pharmaceutical impurities: Two case studies

For more information, please read the Measurement Matters brochure.

Most Recent Posts

Matt Maurer interviewed by StratCann on World Cup-themed bong

Matt Maurer, Chair of our Cannabis Law and Franchise Law Groups, was recently interviewed by StratCann on the strict rules surrounding Cannabis market...
Jun 16, 2026

Matt Maurer interviewed by StratCann on strict rules surrounding Cannabis marketing during the 2026 FIFA World Cup

Matt Maurer, Chair of our Cannabis Law and Franchise Law Groups, was interviewed by StratCann on the strict rules surrounding Cannabis marketing, esp...
May 20, 2026

President Trump Signs Executive Order Initiating the Process to Reschedule Cannabis from Schedule I to Schedule III

Yesterday, on December 18, 2025, President Donald Trump signed an executive order directing the Attorney General...
Dec 19, 2025